Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer-Reference-Cited by-同舟云学术

Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer

Published:2023-12-09 Issue:1 Volume:204 Page:107-116
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Olsson Linnea T.^ORCID,Hamilton Alina M.,Van Alsten Sarah C.,Lund Jennifer L.,Stürmer Til,Nichols Hazel B.,Reeder-Hayes Katherine E.,Troester Melissa A.

Funder

National Cancer Institute

Susan G. Komen

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-023-07164-y.pdf

Reference20 articles.

1. Freedman RA, Vaz-Luis I, Barry WT, Lii H, Lin NU, Winer EP, Keating NL (2014) Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy. Breast Cancer Res Treat 145:491–501

2. Griggs et al (2012) Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample. J Clin Oncol. https://doi.org/10.1200/JCO.2012.41.9564

3. Kurian AW, Lichtensztajn DY, Keegan TH, Leung RW, Shema SJ, Hershman DL, Kushi LH, Habel LA, Kolevska T, Caan BJ, Gomez SL (2013) Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004–2007. Breast Cancer Res Treat 137:247–260

4. Lipscomb J, Gillespie TW, Goodman M, Richardson LC, Pollack LA, Ryerson AB, Ward KC (2012) Black–white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US. Breast Cancer Res Treat 133:285–296

5. Enewold L, Penn DC, Stevens JL, Harlan LC (2018) Black/white differences in treatment and survival among women with stage IIIB-IV breast cancer at diagnosis: a US population-based study. Cancer causes & control : CCC 29(7):657–665. https://doi.org/10.1007/s10552-018-1045-9